. 2019 Jun 3;21(8):1925–1934. doi: 10.1111/dom.13753

Table 1.

Characteristics of the four profiles: Outcome = renal function preservation

Profile		Learning dataset					Validation dataset
		N (%)	Class effect (within the profile)		Class benefit (within vs. without the profile)		N (%)	Class effect (within the profile)			Class benefit (within vs. without the profile)
		N (%)	aOR	P value	Ratio of aORs	P value	N (%)	aOR	P value	BHP value	Ratio of aORs	P value	BH P value
A. Hyperlipidaemia	No	724 (20)	2.2	0.0009	2.1	0.0025	296 (19)	2.7	0.0053	0.0639	2.8	0.0054	0.0646
eGFR	≥79 mL/min/1.73 m²	724 (20)	2.2	0.0009	2.1	0.0025	296 (19)	2.7	0.0053	0.0639	2.8	0.0054	0.0646
B. eGFR	≥79 mL/min/1.73 m²	556 (15)	2.7	0.0023	2.4	0.0074	238 (15)	3.0	0.0184	0.0752	2.9	0.0293	0.139
Duration of diabetes	≤1.2 years	556 (15)	2.7	0.0023	2.4	0.0074	238 (15)	3.0	0.0184	0.0752	2.9	0.0293	0.139
C. eGFR	≥75 mL/min/1.73 m²	430 (12)	2.3	0.0032	2.2	0.0086	198 (13)	2.6	0.0212	0.0752	2.5	0.0348	0.139
Antithrombotic agents	Yes	430 (12)	2.3	0.0032	2.2	0.0086	198 (13)	2.6	0.0212	0.0752	2.5	0.0348	0.139
D. Haemoglobin	≤13.4 g/dL	384 (10)	2.7	0.0009	2.0	0.0254	176 (11)	3.3	0.0251	0.0752	2.6	0.073	0.2189
LDL cholesterol	≥95.1 mg/dL	384 (10)	2.7	0.0009	2.0	0.0254	176 (11)	3.3	0.0251	0.0752	2.6	0.073	0.2189

Note: Bold font indicates statistical significance at risk levels of 5% for P values and 10% for BH P values.

Abbreviations: aOR, adjusted odds ratio; BH, Benjamini–Hochberg; eGFR, estimated glomerular filtration rate.